Evidence map›Paper›PMID 41476471›Full record

ArticleACS omega2025

Fluorogenic Substrate for Monitoring Activity of Muralytic Enzymes.

Marcell Simon, Amber L B Mogg, Chloë F Klein, Kaitlyn M Hohl, Carlos Gomez, Sierra J Williams

Abstract read
In one paragraph

Article in ACS omega, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Marcell SimonDepartment of Natural Sciences of Pitzer and Scripps Colleges, Claremont, California 91711, United States.ORCID https://orcid.org/0009-0008-7006-6861
Amber L B MoggDepartment of Natural Sciences of Pitzer and Scripps Colleges, Claremont, California 91711, United States.
Chloë F KleinDepartment of Natural Sciences of Pitzer and Scripps Colleges, Claremont, California 91711, United States.
Kaitlyn M HohlDepartment of Natural Sciences of Pitzer and Scripps Colleges, Claremont, California 91711, United States.
Carlos GomezDepartment of Natural Sciences of Pitzer and Scripps Colleges, Claremont, California 91711, United States.
Sierra J WilliamsDepartment of Natural Sciences of Pitzer and Scripps Colleges, Claremont, California 91711, United States.ORCID https://orcid.org/0000-0002-0519-8357

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antibiotic-resistant infections are one of the most common causes of morbidity and mortality around the world. The accelerated evolutionary rate of bacteria makes finding effective antibiotics to treat infections difficult. A promising alternative to traditional antibiotics is muralytic enzymes, which are effective at killing bacteria with little evidence of bacterial defense mechanisms. However, there are a lack of tools available to assess their activity, and their engineered variants, in a high-throughput manner, making it difficult to develop effective therapeutics. In this work, we report a new internally quenched substrate that can report on the activity of enzymes that lyse Gram-positive bacteria. As a proof of study, the substrate was "turned on" by the catalytic domains of both LytM and lysostaphin in bacterial lysate, with a robust signal over background. Additionally, the synthetic substrate was able to report on the activity differences between the native enzymes and their mutants. A mock screen study showed that the substrate could be used to assess the activity of multiple samples in a high-throughput manner. This work provides additional tools that can be used to characterize existing and new enzyme therapeutics and lays the groundwork for tools that can be expanded to other lytic enzymes.

Identifiers

PMID41476471
PMCPMC12750271

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.